BRADY CORP

BRC

Brady Corporation manufactures and supplies identification solutions and workplace safety products that identify and protect premises, products, and people in the Americas, Asia, Europe, and Australia.

About the company

Country: United StatesPrice: $82.71Market Cap: $3.9B

Investment snapshot

41%positive consensus

Scored 1d ago

Positive

BUY / PASS

Neutral / negative

3 / 7

NEUTRAL / FAIL

Median fair value

$45.13

-45.4% vs price

Models with upside

0 / 17

Positive margin of safety

Strongest signal

All 12 investors pass BRC's debt & leverage

Key risk

BRC overvalued: all 6 models price fair value below $82.71 (median $45.13)

Framework analysis

Verdict	Meaning
BUY	Positive purchase signal: the framework's buy requirements are met.
PASS	The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRAL	Neither a positive nor negative conclusion. It does not mean to hold an existing position.
FAIL	The company does not clear the framework's requirements.
Ranked	Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

Metric	Graham Defensive Value	Buffett Quality Compounder	Lynch GARP	Greenblatt Magic Formula	Piotroski F-Score	Dreman Contrarian Value	Munger Quality Focus	Pabrai Dhandho Framework	Akre Three-Legged Stool	Marks Risk-Aware Value	Ackman Activist Value	Templeton Global Bargain Hunter	Sleep Scale Economies Shared	Asness Systematic Factors	Neff Low-P/E Total Return	Schloss Asset-Value Discipline	O'Shaughnessy Systematic Factor Composite
Verdict	FAIL	PASS	FAIL	BUY · Rank #312 (Top 10.1%)	PASS	PASS	BUY	FAIL	PASS	FAIL	NEUTRAL	FAIL	NEUTRAL	BUY	FAIL	NEUTRAL	FAIL
Score
Analysis	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…
Intrinsic Value (annual)	N/A		N/A		N/A	N/A				N/A		N/A	N/A	N/A	N/A	N/A	N/A
Margin of Safety	N/A	-66.4%	N/A	-114.2%	N/A	N/A	-81.2%	-95.8%	-24.4%	N/A	-85.4%	N/A	N/A	N/A	N/A	N/A	N/A
Financial Basis	TTM ended 2026-07-31 · Balance sheet at 2026-07-31 · Annual history · FY 2025 Latest source filing: 2026-09-03 Score computed: 2026-11-14	Annual history · FY 2025 · TTM ended 2026-07-31 Latest source filing: 2026-09-03 Score computed: 2026-11-14	Annual history · FY 2025 · Balance sheet at 2026-07-31 · TTM ended 2026-07-31 vs 2025-07-31 · TTM ended 2026-07-31 Latest source filing: 2026-09-03 Score computed: 2026-11-14	TTM ended 2026-07-31 Latest source filing: 2026-09-03 Score computed: 2026-11-14	Annual history · FY 2025 Latest source filing: 2025-09-04 Score computed: 2026-11-14	Annual history · FY 2025 · TTM ended 2026-07-31 · Balance sheet at 2026-07-31 · Market data at 2026-11-01 Latest source filing: 2026-09-03 Score computed: 2026-11-14	Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-07-31 · Balance sheet at 2026-07-31 Latest source filing: 2026-09-03 Score computed: 2026-11-14	Qualitative assessment · Annual history · FY 2025 Latest source filing: 2025-09-04 Score computed: 2026-11-14	Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-07-31 · Balance sheet at 2026-07-31 Latest source filing: 2026-09-03 Score computed: 2026-11-14	Annual history · FY 2025 · TTM ended 2026-07-31 · Qualitative assessment Latest source filing: 2026-09-03 Score computed: 2026-11-14	Annual history · FY 2025 · TTM ended 2026-07-31 · Balance sheet at 2026-07-31 · Market data at 2026-11-01 Latest source filing: 2026-09-03 Score computed: 2026-11-14	Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-07-31 Latest source filing: 2026-09-03 Score computed: 2026-11-14	Annual history · FY 2025 · Qualitative assessment Latest source filing: 2025-09-04 Score computed: 2026-11-14	TTM ended 2026-07-31 · Balance sheet at 2026-07-31 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025 Latest source filing: 2026-09-03 Score computed: 2026-11-14	Annual history · FY 2025 · TTM ended 2026-07-31 Latest source filing: 2026-09-03 Score computed: 2026-11-14	Annual history · FY 2025 · Balance sheet at 2026-07-31 Latest source filing: 2026-09-03 Score computed: 2026-11-14	TTM ended 2026-07-31 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-09-03 Score computed: 2026-11-14

Where It Passes

Debt & Leverage100% pass✓ 15▾
All 12 investors pass BRC's debt & leverage
LT Debt vs Net Current AssetsLT Debt $15.0M vs NCA $333.0M
✓GrahamLT Debt <= Net Current Assets
Debt/Equity & Interest CoverageD/E: 0.01, IC: 27.2x
✓BuffettD/E < 0.5 AND Interest Coverage > 5x
Total Debt / Equity0.01
✓Lynch< 0.33
Cash - Long-term Debt$172.2M
✓LynchPositive preferred
LT Debt / Total Assets Change6.00% -> 5.75%
✓PiotroskiDecreased YoY
Current Assets / Current Liabilities1.94
✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)
Total Debt / Shareholders' Equity0.01
✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
Debt Levels0.01
✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3
Interest Coverage & Debt/EBITDAIC=27.2x, D/EBITDA=0.0x
✓MarksInterest Coverage > 3x; Debt/EBITDA < 4x
Total Debt / Shareholders Equity0.01
✓Ackman<= 1.0
Negative debt-to-equity (higher means less debt)-0.0110; #631/4210 (top 15.0%)
✓AsnessTop 30% of eligible cross-section
Efficiency63% pass✓ 7✗ 4▾
5 of 8 pass — Graham, Piotroski and Akre object
Current Ratio1.94
✗Graham>= 2.0
ROIC (3-5 yr avg)18.1%
✓Buffett> 10%
ROIC - WACC+8.1%
✓BuffettPositive (WACC = 10%)
EBIT / (NWC + Net Fixed Assets)65.8%
✓Greenblatt> 25%
Current Ratio Change YoY2.27 -> 1.88
✗PiotroskiIncreased YoY
Revenue / Total Assets Change YoY0.89x -> 0.87x
✗PiotroskiImproved YoY
Current Assets / Current Liabilities1.94
✓Dreman> 1.5
Return on Invested Capital15.2%
✓Munger> 15%
ROIC (high and growing)FY2023: ROIC=17.1%; FY2024: ROIC=16.6%; FY2025: ROIC=14.5%
✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
Reinvestment Rate x ROIC11.8% (RR=78% x ROIC=15.2%)
✓AkreReinvestment Rate * ROIC > 10%
ROIC (5-year)5/5 years above 12% (latest 14.5%)
✓SleepROIC > 12% in a majority of years

Where It Falls Short

Valuation models0% pass✗ 6▾
BRC overvalued: all 6 models price fair value below $82.71 (median $45.13)
Buffett fair value$49.72
✗Buffett-66.4% margin vs $82.71
Greenblatt fair value$38.62
✗Greenblatt-114.2% margin vs $82.71
Munger fair value$45.64
✗Munger-81.2% margin vs $82.71
Pabrai fair value$42.24
✗Pabrai-95.8% margin vs $82.71
Akre fair value$66.47
✗Akre-24.4% margin vs $82.71
Ackman fair value$44.61
✗Ackman-85.4% margin vs $82.71
Valuation8% pass✓ 3✗ 25▾
12 of 13 flag BRC's valuation — Graham, Lynch, Greenblatt +9 more
Net income / market capitalization+5.29%; #1591/6340 (top 25.1%)
✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
Price / 3-yr avg EPS
✗Graham<= 15x
Price-to-Book Ratio3.3x
✗Graham<= 1.5x
P/E x P/B
✗Graham<= 22.5
Basic earnings-growth PEG (dividends excluded)
✗Lynch< 1.0 (ideally < 0.5)
EBIT / Enterprise Value7.1%
✗Greenblatt> 10%
Earnings Yield + ROC AssessmentEY=7.1%, ROC=65.8%
✗GreenblattBoth EY > 10% and ROC > 25%
Price / EPS
✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
Price / (CFO / Shares)22.0x
✗Dreman< 8x
Price / Book Value per Share3.3x
✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
Valuation ReasonablenessOE Yield=5.1%
✓MungerP/E < 25 or Owner Earnings Yield > 5%
P/E or FCF YieldFCF Yield=4.0%
✗PabraiP/E < 15 or FCF Yield > 10%
P/B or P/E vs. Historical AverageP/B=3.3x
✗MarksP/E < 15 or P/B < 2.0
Discount to Intrinsic Value
✗Marks>= 20% below intrinsic value
Price / FCF per Share25.9x
✗Ackman<= 25
Price vs. Trailing Low122% of trailing low ($67.97)
✗Templeton<= 120% of trailing low (certified split-adjusted live window)
Positive book equity / market capitalization+0.3500; #3462/6449 (top 53.7%)
✗AsnessTop 30% of eligible cross-section
Price / Diluted EPS
✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
(EPS CAGR % + Dividend Yield %) / P/E
✗Neff> 0.7 (Neff's published traditional edge)
Price / Tangible Book Value per Share9.70x
✗SchlossP/TBV <= 1.00x (app cutoff)
Book Value per Share Change+75.5%
✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
Revenue / market capitalization+0.4283; #2836/5247 (top 54.0%)
✗OshaughnessyTop 10% of eligible cross-section
(Operating cash flow - capex) / market capitalization+4.97%; #1588/4519 (top 35.1%)
✗OshaughnessyTop 10% of eligible cross-section
Trailing six-month price return through the evaluation date-1.27%; #2876/6202 (top 46.4%)
✗OshaughnessyTop 10% of eligible cross-section
Growth13% pass✓ 1✗ 12▾
7 of 8 flag BRC's growth — Graham, Lynch, Dreman +4 more
EPS Growth (3-yr avg, 10-yr window)
✗Graham>= 33% growth
Basic earnings-growth PEG (dividends excluded)
✗Lynch< 1.0 (ideally < 0.5)
3-5 Year EPS CAGR
✗Lynch15-30% (Fast Grower); > 0% to pass
Inventory Growth vs Revenue GrowthInv: 12.1% vs Rev: 9.8%
✗LynchInventory growth < Revenue growth
EPS Growth Direction
✗DremanPositive over recent years
EPS CAGR
✗Dreman> 5% annualized
Positive Net Income Frequency22/25 years positive
✓MarksPositive net income in >= 7 of last 10 years
3yr Median Revenue Growth2.3%
✗Ackman>= 5%
Positive EPS Growth Frequency
✗AckmanPositive EPS growth in >= 3 of last 5 years
5-Year EPS CAGR
✗Templeton> 0% (5-year EPS CAGR)
Revenue growth vs. gross and operating margin trendgross margin 49.4% -> 50.3%, operating margin 16.9% -> 15.6%
✗SleepRevenue rising; gross margin flat or falling; operating margin holding
5-year Revenue CAGR7.0%
✗SleepCAGR > 7%
3-5 Year Diluted EPS CAGR
✗Neff7%-20% annualized
Profitability19% pass✓ 13✗ 22▾
13 of 16 flag BRC's profitability — Graham, Buffett, Lynch +10 more
Net income / market capitalization+5.29%; #1591/6340 (top 25.1%)
✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
Positive EPS (10 years)0/25 years positive
✗GrahamPositive EPS every year for 10 years
EPS Growth (3-yr avg, 10-yr window)
✗Graham>= 33% growth
Net Income Positive (10+ years)22/25 years positive
✗BuffettPositive every year for 10+ years
ROE (up to 5-year arithmetic mean)16.4%
✓Buffett> 15% arithmetic mean (app rule)
Operating Margin (10-yr trend)15.6% (latest)
✗BuffettStable or rising over 10 years
Free Cash Flow Proxy$202.3M
✓BuffettPositive and growing
Earnings Variance (10-yr CoV)
✗BuffettCoV < 0.3
Retained Earnings Effectiveness
✗Buffett$1 retained -> > $1 market value created
Basic earnings-growth PEG (dividends excluded)
✗Lynch< 1.0 (ideally < 0.5)
3-5 Year EPS CAGR
✗Lynch15-30% (Fast Grower); > 0% to pass
ROE15.1%
✓Lynch> 15%
EBIT / Enterprise Value7.1%
✗Greenblatt> 10%
Earnings Yield + ROC AssessmentEY=7.1%, ROC=65.8%
✗GreenblattBoth EY > 10% and ROC > 25%
Net Income / Total Assets10.91%
✓PiotroskiROA > 0
ROA Change YoY13.01% -> 10.91% (delta: -2.10%)
✗PiotroskiCurrent ROA > Prior ROA
(CFO / Total Assets) vs ROACFO/Assets=10.45%, ROA=10.91%
✗PiotroskiCFO/Assets > ROA
Gross Margin Change YoY51.3% -> 50.3%
✗PiotroskiImproved YoY
Pre-Tax Income / Revenue15.6%
✓Dreman>= 8%
Net Income / Shareholders' Equity15.1%
✓Dreman> 12%
Margin of SafetyP/B=3.3x
✗PabraiP/B < 1.5 or P/E < 15
Return on Equity17.3% (3-yr avg)
✗AkreROE > 20% (3-year avg)
Discount to Intrinsic Value
✗Marks>= 20% below intrinsic value
Positive Net Income Frequency22/25 years positive
✓MarksPositive net income in >= 7 of last 10 years
Operating Income / Revenue15.9%
✓Ackman>= 15%
Net Income / Shareholders Equity15.1%
✓Ackman>= 15%
5-Year EPS CAGR
✗Templeton> 0% (5-year EPS CAGR)
Operating Margin Trend16.9% (2023) -> 15.6% (2025)
✗TempletonNon-negative operating-margin trend over 3 years
Revenue growth vs. gross and operating margin trendgross margin 49.4% -> 50.3%, operating margin 16.9% -> 15.6%
✗SleepRevenue rising; gross margin flat or falling; operating margin holding
Gross profit / total assets+46.43%; #751/3702 (top 20.3%)
✓AsnessTop 30% of eligible cross-section
Net income / positive book equity+15.13%; #1152/5226 (top 22.0%)
✓AsnessTop 30% of eligible cross-section
Negative 5-year standard deviation of ROA-0.0130; #1010/5884 (top 17.2%)
✓AsnessTop 30% of eligible cross-section
3-5 Year Diluted EPS CAGR
✗Neff7%-20% annualized
Positive Diluted-EPS Years
✗Schloss>= 70% positive over 5-10 observed years (app rule)
Cash Flow50% pass✓ 7✗ 5▾
5 of 10 pass — Piotroski, Dreman, Pabrai +2 more object
Free Cash Flow Proxy$202.3M
✓BuffettPositive and growing
FCF Positive and Growing$192.7M
✓LynchPositive and growing
Operating Cash Flow$181.2M
✓PiotroskiCFO > 0
(CFO / Total Assets) vs ROACFO/Assets=10.45%, ROA=10.91%
✗PiotroskiCFO/Assets > ROA
Price / (CFO / Shares)22.0x
✗Dreman< 8x
P/E or FCF YieldFCF Yield=4.0%
✗PabraiP/E < 15 or FCF Yield > 10%
FCF Positive17/17 years FCF positive
✓MarksPositive FCF in majority of recent years
(OCF - CapEx) / Market Cap4.8%
✓Ackman>= 4%
Price / FCF per Share25.9x
✗Ackman<= 25
Positive Operating Cash Flow frequency25/25 years positive
✓SleepPositive OCF in >= 70% of available years
Operating Cash Flow - Capital Expenditures$192.7M
✓Neff> $0 (app proxy for a strong fundamental case)
(Operating cash flow - capex) / market capitalization+4.97%; #1588/4519 (top 35.1%)
✗OshaughnessyTop 10% of eligible cross-section
Verdicts50% pass✓ 7✗ 7▾
Split decision: 7 FAIL · 4 PASS · 3 NEUTRAL · 2 BUY
Overall verdict
✗GrahamFAIL (3/9)✓BuffettPASS (5/9)✗LynchFAIL (4/7)✓GreenblattRank #312✓PiotroskiPASS (F-Score 4)✓DremanPASS (5/11)✓MungerBUY (4/4)✗PabraiFAIL (0/3)✓AkrePASS (3/6)✗MarksFAIL (3/5)•AckmanNEUTRAL (6/9)✗TempletonFAIL (3/8)•SleepNEUTRAL (4/6)✓AsnessBUY (Rank #180/2370 (Top 7.6%))✗NeffFAIL (3/6)•SchlossNEUTRAL (4/7)✗OshaughnessyFAIL (Rank #600/963 (Top 62.3%))

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Miscellaneous Manufacturing

Size: Mid Cap($3.9B)

Revenue: $1.5B+12.8% YoY

Net Income: $189.3M-4.0% YoY

Financial Snapshot

Operating Margin15.6%

Return on Equity15.9%

Debt / Equity0.08

Current Ratio1.88

Buybacks (1y)$50.8M

Buybacks (2y)$123.1M

Shares Retired0.8% / 3.6% 2y

Similar Companies

No peer companies found in this industry.

Shareholder Return

Fiscal 2025

Retired 0.8% of shares last year, 3.6% over two.

Buybacks: $50.8M
Dividends: $45.5M

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

Metric	TTM · 2026-07-31 2025-08-01 – 2026-07-31 Sources · derived quarter values 10-Q · 2025-11-17 10-Q · 2026-02-19 10-Q · 2026-05-18 10-K · 2026-09-03 Derived from cumulative filings: operating cash flow, capex, dividends paid, buybacks, revenue, net income, operating income, gross profit, ebit, pre tax income, interest expense, depreciation amortization.	Q4 FY 2026 2026-05-01 – 2026-07-31 Sources · derived quarter values 10-K · 2026-09-03 Derived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, interest expense, operating cash flow, depreciation amortization, capex, dividends paid, buybacks.	Q3 FY 2026 2026-02-01 – 2026-04-30 Sources · derived quarter values 10-Q · 2026-05-18 Derived from cumulative filings: operating cash flow, capex, dividends paid, buybacks.	Q2 FY 2026 2025-11-01 – 2026-01-31 Sources · derived quarter values 10-Q · 2026-02-19 Derived from cumulative filings: operating cash flow, capex, dividends paid, buybacks.	Q1 FY 2026 2025-08-01 – 2025-10-31 Sources 10-Q · 2025-11-17	FY 2025 Sources 10-K · 2025-09-04	FY 2024 Sources 10-K · 2024-09-06	FY 2023 Sources 10-K · 2023-09-05	FY 2022 Sources 10-K · 2022-09-01	FY 2021 Sources 10-K · 2021-09-02
Market Cap	$3.9Bcurrent	--	--	--	--	$4.1Best.	$3.5Best.	$2.9Best.	$2.6Best.	$2.5Best.
Revenue	$1.7B↑10%	$436.9M↑10%	$435.2M↑14%	$384.1M↑8%	$405.3M↑7%	$1.5B↑13%	$1.3B↑1%	$1.3B↑2%	$1.3B↑14%	$1.1B
Operating Income	$263.5M↑11%	$60.1M↑1%	$73.2M↑9%	$62.2M↑21%	$68.0M↑15%	$236.6M↓3%	$243.4M↑8%	$225.2M↑17%	$193.0M↑15%	$167.1M
Net Income	$205.4M↑9%	$45.6M↓9%	$57.8M↑11%	$48.1M↑19%	$53.9M↑15%	$189.3M↓4%	$197.2M↑13%	$174.9M↑17%	$150.0M↑16%	$129.7M
EPS (Diluted)	--	--	--	--	--	--	--	--	--	--
Gross Margin	51.7%↑3%	52.9%↑5%	51.8%↑2%	50.6%↑3%	51.5%↑2%	50.3%↓2%	51.3%↑4%	49.4%↑2%	48.5%↓1%	49.0%
Operating Margin	15.9%↑1%	13.8%↓8%	16.8%↓4%	16.2%↑13%	16.8%↑7%	15.6%↓14%	18.1%↑7%	16.9%↑14%	14.8%↑2%	14.6%
ROE	15.1%↓5%	—	—	—	—	15.9%↓14%	18.5%↑5%	17.6%↑7%	16.5%↑22%	13.5%
Total Debt	$15.0M↓85%	$15.0M↓85%	$26.9M	$78.7M	$115.9M	$99.8M↑10%	$90.9M↑83%	$49.7M↓48%	$95.0M↑150%	$38.0M
Shareholders' Equity	$1.4B↑14%	$1.4B↑14%	$1.3B↑15%	$1.3B↑17%	$1.2B↑12%	$1.2B↑12%	$1.1B↑8%	$990.9M↑9%	$911.3M↓5%	$963.0M
Current Ratio	1.94↑3%	1.94↑3%	2.01↑8%	2.13↑12%	2.07↑12%	1.88↓17%	2.27↑11%	2.03↑4%	1.95↑8%	1.81
Debt / Equity	0.01↓87%	0.01↓87%	0.02	0.06	0.09	0.08↓2%	0.09↑70%	0.05↓52%	0.10↑164%	0.04
Operating Cash Flow	$244.1M↑35%	$79.2M↑36%	$78.2M↑31%	$53.3M↑35%	$33.4M↑43%	$181.2M↓29%	$255.1M↑22%	$209.1M↑77%	$118.4M↓42%	$205.7M
Free Cash Flow	$192.7M↑25%	$60.7M↑23%	$67.2M↑21%	$42.3M↑30%	$22.4M↑39%	$153.6M↓12%	$175.2M↓8%	$189.9M↑152%	$75.3M↓58%	$178.5M